Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders and diabetes. Chaihu Shugan powder (CSP) is a traditional Chinese medicine with a significant therapeutic effect on metabolic diseases, such as NAFLD. However, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Sisi, Zhao, Shuai, Huang, Xiaoyan, Feng, Yuchao, Li, Zhishang, Chen, Li, Huang, Peiying, Guan, Hansu, Zhang, Haobo, Wu, Qihua, Chen, Bojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512055/
https://www.ncbi.nlm.nih.gov/pubmed/36172180
http://dx.doi.org/10.3389/fphar.2022.967623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512055/
https://www.ncbi.nlm.nih.gov/pubmed/36172180
http://dx.doi.org/10.3389/fphar.2022.967623

Ejemplares similares